DDrare: Database of Drug Development for Rare Diseases

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

A B C D E F G H I J K L M N O PQR S T U V WXYZother

152 / 286 pathways

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	指定難病告示番号
1	Acute myeloid leukemia 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2	Adherens junction 💬	1件: FGFR1 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
3	Adipocytokine signaling pathway 💬	1件: JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
4	Adipocytokine signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
5	Adipocytokine signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
6	Adipocytokine signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
7	Adrenergic signaling in cardiomyocytes 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
8	Adrenergic signaling in cardiomyocytes 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
9	Adrenergic signaling in cardiomyocytes 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
10	Adrenergic signaling in cardiomyocytes 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
11	African trypanosomiasis 💬	4件: IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
12	African trypanosomiasis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
13	AGE-RAGE signaling pathway in diabetic complications 💬	5件: CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
14	AGE-RAGE signaling pathway in diabetic complications 💬	1件: JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
15	AGE-RAGE signaling pathway in diabetic complications 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
16	Allograft rejection 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
17	Allograft rejection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
18	Alzheimer disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
19	Alzheimer disease 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
20	Alzheimer disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
21	Alzheimer disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
22	Alzheimer disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
23	Alzheimer disease 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
24	Alzheimer disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
25	Amoebiasis 💬	4件: IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
26	Amoebiasis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
27	Amphetamine addiction 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
28	Amphetamine addiction 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
29	Amphetamine addiction 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
30	AMPK signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
31	Amyotrophic lateral sclerosis 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
32	Amyotrophic lateral sclerosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
33	Amyotrophic lateral sclerosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
34	Amyotrophic lateral sclerosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
35	Amyotrophic lateral sclerosis 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
36	Amyotrophic lateral sclerosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
37	Amyotrophic lateral sclerosis 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
38	Antifolate resistance 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
39	Antifolate resistance 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
40	Antigen processing and presentation 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
41	Antigen processing and presentation 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
42	Apelin signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
43	Apoptosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
44	Apoptosis 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
45	Asthma 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
46	Asthma 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
47	Autoimmune thyroid disease 💬	1件: IL10 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
48	Autophagy - animal 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
49	Autophagy - other 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
50	Axon guidance 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
51	Axon guidance 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
52	Axon guidance 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
53	B cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
54	B cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
55	B cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
56	Bladder cancer 💬	1件: FGFR3 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
57	Breast cancer 💬	2件: FGFR1, FLT4 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
58	Breast cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
59	C-type lectin receptor signaling pathway 💬	4件: IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
60	C-type lectin receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
61	C-type lectin receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
62	C-type lectin receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
63	C-type lectin receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
64	Calcium signaling pathway 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
65	Calcium signaling pathway 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
66	Calcium signaling pathway 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
67	Calcium signaling pathway 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
68	Calcium signaling pathway 💬	1件: CYSLTR1 💬	D00529 💬	Montelukast	5件: 13, 46, 85, 98, 228 💬
69	Calcium signaling pathway 💬	1件: CYSLTR1 💬	D08229 💬	Montelukast	5件: 13, 46, 85, 98, 228 💬
70	Calcium signaling pathway 💬	8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
71	Calcium signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
72	Calcium signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
73	Calcium signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
74	cAMP signaling pathway 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
75	cAMP signaling pathway 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
76	cAMP signaling pathway 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
77	cAMP signaling pathway 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
78	Cellular senescence 💬	2件: IL1A, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
79	Cellular senescence 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
80	Cellular senescence 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
81	Cellular senescence 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
82	Cellular senescence 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
83	Central carbon metabolism in cancer 💬	5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
84	Central carbon metabolism in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
85	cGMP-PKG signaling pathway 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
86	cGMP-PKG signaling pathway 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
87	cGMP-PKG signaling pathway 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
88	cGMP-PKG signaling pathway 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
89	cGMP-PKG signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
90	cGMP-PKG signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
91	cGMP-PKG signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
92	Chagas disease 💬	5件: CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
93	Chagas disease 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
94	Chagas disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
95	Chemokine signaling pathway 💬	1件: CCL2 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
96	Chemokine signaling pathway 💬	1件: JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
97	Choline metabolism in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
98	Choline metabolism in cancer 💬	2件: PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
99	Cholinergic synapse 💬	1件: JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
100	Colorectal cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
101	Coronavirus disease - COVID-19 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102	Coronavirus disease - COVID-19 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
103	Coronavirus disease - COVID-19 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
104	Coronavirus disease - COVID-19 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
105	Cytokine-cytokine receptor interaction 💬	6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
106	Cytokine-cytokine receptor interaction 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
107	Cytokine-cytokine receptor interaction 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
108	Cytokine-cytokine receptor interaction 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
109	Cytosolic DNA-sensing pathway 💬	2件: IL1B, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
110	Diabetic cardiomyopathy 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
111	Dilated cardiomyopathy 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
112	Dilated cardiomyopathy 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
113	Dopaminergic synapse 💬	3件: PPP3CA, PPP3CB, PPP3CC 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
114	Dopaminergic synapse 💬	3件: PPP3CA, PPP3CB, PPP3CC 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
115	Dopaminergic synapse 💬	3件: PPP3CA, PPP3CB, PPP3CC 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
116	Drug metabolism - other enzymes 💬	2件: IMPDH1, IMPDH2 💬	D05096 💬	Mycophenolic acid	34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
117	EGFR tyrosine kinase inhibitor resistance 💬	5件: FGFR2, FGFR3, KDR, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
118	EGFR tyrosine kinase inhibitor resistance 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
119	EGFR tyrosine kinase inhibitor resistance 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
120	EGFR tyrosine kinase inhibitor resistance 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
121	EGFR tyrosine kinase inhibitor resistance 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
122	Endocrine and other factor-regulated calcium reabsorption 💬	1件: VDR 💬	D00188 💬	Cholecalciferol	23件: 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
123	Endocrine resistance 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
124	Endocytosis 💬	3件: FGFR2, FGFR3, PDGFRA 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
125	Endocytosis 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
126	Epstein-Barr virus infection 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
127	Epstein-Barr virus infection 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
128	Epstein-Barr virus infection 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
129	Epstein-Barr virus infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
130	ErbB signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
131	Fc epsilon RI signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
132	Fc epsilon RI signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
133	Fluid shear stress and atherosclerosis 💬	4件: CCL2, IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
134	Fluid shear stress and atherosclerosis 💬	1件: KDR 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
135	Fluid shear stress and atherosclerosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
136	Focal adhesion 💬	5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
137	FoxO signaling pathway 💬	2件: IL10, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
138	Gap junction 💬	2件: PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
139	Gastric cancer 💬	1件: FGFR2 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
140	Gastric cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
141	Glioma 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
142	Glioma 💬	2件: PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
143	Glucagon signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
144	Glucagon signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
145	Glucagon signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
146	Glutamatergic synapse 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
147	Glutamatergic synapse 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
148	Glutamatergic synapse 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
149	Graft-versus-host disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
150	Graft-versus-host disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
151	Growth hormone synthesis, secretion and action 💬	1件: JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
152	Growth hormone synthesis, secretion and action 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
153	Hematopoietic cell lineage 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
154	Hematopoietic cell lineage 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
155	Hematopoietic cell lineage 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
156	Hepatitis B 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
157	Hepatitis B 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
158	Hepatitis B 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
159	Hepatitis B 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
160	Hepatitis C 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
161	Hepatitis C 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
162	Hepatitis C 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
163	Hepatitis C 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
164	Hepatocellular carcinoma 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
165	Herpes simplex virus 1 infection 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
166	Herpes simplex virus 1 infection 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
167	Herpes simplex virus 1 infection 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
168	Herpes simplex virus 1 infection 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
169	Herpes simplex virus 1 infection 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
170	Herpes simplex virus 1 infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
171	HIF-1 signaling pathway 💬	1件: FLT1 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
172	HIF-1 signaling pathway 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
173	HIF-1 signaling pathway 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
174	HIF-1 signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
175	Human cytomegalovirus infection 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
176	Human cytomegalovirus infection 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
177	Human cytomegalovirus infection 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
178	Human cytomegalovirus infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
179	Human cytomegalovirus infection 💬	1件: PDGFRA 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
180	Human cytomegalovirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
181	Human cytomegalovirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
182	Human cytomegalovirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
183	Human cytomegalovirus infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
184	Human immunodeficiency virus 1 infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
185	Human immunodeficiency virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
186	Human immunodeficiency virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
187	Human immunodeficiency virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
188	Human immunodeficiency virus 1 infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
189	Human immunodeficiency virus 1 infection 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
190	Human papillomavirus infection 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
191	Human papillomavirus infection 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
192	Human papillomavirus infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
193	Human papillomavirus infection 💬	1件: PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
194	Human papillomavirus infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
195	Human papillomavirus infection 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
196	Human T-cell leukemia virus 1 infection 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
197	Human T-cell leukemia virus 1 infection 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
198	Human T-cell leukemia virus 1 infection 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
199	Human T-cell leukemia virus 1 infection 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
200	Human T-cell leukemia virus 1 infection 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
201	Human T-cell leukemia virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
202	Human T-cell leukemia virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
203	Human T-cell leukemia virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
204	Huntington disease 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
205	Huntington disease 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
206	Hypertrophic cardiomyopathy 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
207	Hypertrophic cardiomyopathy 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
208	IL-17 signaling pathway 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
209	IL-17 signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
210	Inflammatory bowel disease 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
211	Inflammatory bowel disease 💬	5件: IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
212	Inflammatory bowel disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
213	Inflammatory mediator regulation of TRP channels 💬	1件: IL1B 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
214	Influenza A 💬	5件: CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
215	Influenza A 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
216	Influenza A 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
217	Influenza A 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
218	Influenza A 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
219	Insulin resistance 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
220	Insulin resistance 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
221	Insulin resistance 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
222	Insulin signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
223	Intestinal immune network for IgA production 💬	2件: IL10, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
224	JAK-STAT signaling pathway 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
225	JAK-STAT signaling pathway 💬	2件: IL10, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
226	JAK-STAT signaling pathway 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
227	JAK-STAT signaling pathway 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
228	JAK-STAT signaling pathway 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
229	JAK-STAT signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
230	JAK-STAT signaling pathway 💬	2件: PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
231	Kaposi sarcoma-associated herpesvirus infection 💬	1件: IFNGR1 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
232	Kaposi sarcoma-associated herpesvirus infection 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
233	Kaposi sarcoma-associated herpesvirus infection 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
234	Kaposi sarcoma-associated herpesvirus infection 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
235	Kaposi sarcoma-associated herpesvirus infection 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
236	Kaposi sarcoma-associated herpesvirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
237	Kaposi sarcoma-associated herpesvirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
238	Kaposi sarcoma-associated herpesvirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
239	Legionellosis 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
240	Legionellosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
241	Leishmaniasis 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
242	Leishmaniasis 💬	4件: IL10, IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
243	Leishmaniasis 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
244	Leishmaniasis 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
245	Leishmaniasis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
246	Long-term potentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
247	Long-term potentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
248	Long-term potentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
249	Longevity regulating pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
250	Longevity regulating pathway - multiple species 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
251	Malaria 💬	5件: CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
252	Malaria 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
253	MAPK signaling pathway 💬	8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
254	MAPK signaling pathway 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
255	MAPK signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
256	MAPK signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
257	MAPK signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
258	MAPK signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
259	Measles 💬	3件: IL1A, IL1B, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
260	Measles 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
261	Measles 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
262	Measles 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
263	Melanoma 💬	3件: FGFR1, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
264	Metabolic pathways 💬	2件: IMPDH1, IMPDH2 💬	D05096 💬	Mycophenolic acid	34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
265	MicroRNAs in cancer 💬	3件: FGFR3, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
266	MicroRNAs in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
267	Mineral absorption 💬	1件: VDR 💬	D00188 💬	Cholecalciferol	23件: 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
268	mTOR signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
269	mTOR signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
270	mTOR signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
271	Natural killer cell mediated cytotoxicity 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
272	Natural killer cell mediated cytotoxicity 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
273	Natural killer cell mediated cytotoxicity 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
274	Natural killer cell mediated cytotoxicity 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
275	Natural killer cell mediated cytotoxicity 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
276	Natural killer cell mediated cytotoxicity 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
277	Necroptosis 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
278	Necroptosis 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
279	Necroptosis 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
280	Necroptosis 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
281	Necroptosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
282	Neuroactive ligand-receptor interaction 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
283	Neuroactive ligand-receptor interaction 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
284	Neuroactive ligand-receptor interaction 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
285	Neuroactive ligand-receptor interaction 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
286	Neuroactive ligand-receptor interaction 💬	1件: CYSLTR1 💬	D00529 💬	Montelukast	5件: 13, 46, 85, 98, 228 💬
287	Neuroactive ligand-receptor interaction 💬	1件: CYSLTR1 💬	D08229 💬	Montelukast	5件: 13, 46, 85, 98, 228 💬
288	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00246 💬	Budesonide	9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
289	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D07981 💬	Fluticasone	3件: 98, 228, 299 💬
290	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01708 💬	Fluticasone propionate	2件: 98, 228 💬
291	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00473 💬	Prednisone	47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
292	Neutrophil extracellular trap formation 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
293	NF-kappa B signaling pathway 💬	2件: IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
294	NF-kappa B signaling pathway 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
295	NOD-like receptor signaling pathway 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
296	NOD-like receptor signaling pathway 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
297	NOD-like receptor signaling pathway 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
298	NOD-like receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
299	Non-alcoholic fatty liver disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
300	Non-alcoholic fatty liver disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
301	Oocyte meiosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
302	Oocyte meiosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
303	Oocyte meiosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
304	Osteoclast differentiation 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
305	Osteoclast differentiation 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
306	Osteoclast differentiation 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
307	Osteoclast differentiation 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
308	Osteoclast differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
309	Osteoclast differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
310	Osteoclast differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
311	Osteoclast differentiation 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
312	Oxytocin signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
313	Oxytocin signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
314	Oxytocin signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
315	Pancreatic cancer 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
316	Pancreatic cancer 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
317	Pancreatic cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
318	Parathyroid hormone synthesis, secretion and action 💬	1件: FGFR1 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
319	Parathyroid hormone synthesis, secretion and action 💬	1件: VDR 💬	D00188 💬	Cholecalciferol	23件: 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
320	Parkinson disease 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
321	Pathogenic Escherichia coli infection 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
322	Pathogenic Escherichia coli infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
323	Pathways in cancer 💬	6件: FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
324	Pathways in cancer 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
325	Pathways in cancer 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
326	Pathways in cancer 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
327	Pathways in cancer 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
328	Pathways in cancer 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
329	Pathways in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
330	Pathways of neurodegeneration - multiple diseases 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
331	Pathways of neurodegeneration - multiple diseases 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
332	Pathways of neurodegeneration - multiple diseases 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
333	Pathways of neurodegeneration - multiple diseases 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
334	Pathways of neurodegeneration - multiple diseases 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
335	Pathways of neurodegeneration - multiple diseases 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
336	Pathways of neurodegeneration - multiple diseases 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
337	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
338	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
339	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
340	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
341	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
342	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
343	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
344	Pertussis 💬	5件: IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
345	Pertussis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
346	Phospholipase D signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
347	Phospholipase D signaling pathway 💬	2件: PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
348	PI3K-Akt signaling pathway 💬	8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
349	PI3K-Akt signaling pathway 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
350	PI3K-Akt signaling pathway 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
351	PI3K-Akt signaling pathway 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
352	PI3K-Akt signaling pathway 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
353	PI3K-Akt signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
354	Prion disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
355	Prion disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
356	Prion disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
357	Prion disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
358	Prion disease 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
359	Prion disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
360	Prolactin signaling pathway 💬	1件: JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
361	Prostate cancer 💬	4件: FGFR1, FGFR2, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
362	Prostate cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
363	Proteasome 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
364	Proteoglycans in cancer 💬	2件: FGFR1, KDR 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
365	Proteoglycans in cancer 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
366	Proteoglycans in cancer 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
367	Proteoglycans in cancer 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
368	Purine metabolism 💬	2件: IMPDH1, IMPDH2 💬	D05096 💬	Mycophenolic acid	34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
369	Rap1 signaling pathway 💬	8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
370	Ras signaling pathway 💬	8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
371	Regulation of actin cytoskeleton 💬	5件: FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
372	Regulation of lipolysis in adipocytes 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
373	Regulation of lipolysis in adipocytes 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
374	Regulation of lipolysis in adipocytes 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
375	Regulation of lipolysis in adipocytes 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
376	Renin secretion 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
377	Renin secretion 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
378	Renin secretion 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
379	Renin secretion 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
380	Renin secretion 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
381	Renin secretion 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
382	Renin secretion 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
383	Rheumatoid arthritis 💬	5件: CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
384	Rheumatoid arthritis 💬	1件: FLT1 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
385	Rheumatoid arthritis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
386	RIG-I-like receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
387	RIG-I-like receptor signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
388	Salivary secretion 💬	1件: ADRB2 💬	D01373 💬	Formoterol	3件: 85, 228, 299 💬
389	Salivary secretion 💬	1件: ADRB2 💬	D05277 💬	Formoterol	3件: 85, 228, 299 💬
390	Salivary secretion 💬	1件: ADRB2 💬	D07990 💬	Formoterol	3件: 85, 228, 299 💬
391	Salivary secretion 💬	1件: ADRB2 💬	D02147 💬	Salbutamol	14件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
392	Salmonella infection 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
393	Salmonella infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
394	Shigellosis 💬	2件: IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
395	Shigellosis 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
396	Shigellosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
397	Signaling pathways regulating pluripotency of stem cells 💬	3件: FGFR1, FGFR2, FGFR3 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
398	Signaling pathways regulating pluripotency of stem cells 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
399	Signaling pathways regulating pluripotency of stem cells 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
400	Sphingolipid signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
401	Sphingolipid signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
402	Spinocerebellar ataxia 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
403	Spinocerebellar ataxia 💬	1件: PSMB5 💬	D03150 💬	Bortezomib	15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
404	Staphylococcus aureus infection 💬	1件: IL10 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
405	Systemic lupus erythematosus 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
406	Systemic lupus erythematosus 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
407	T cell receptor signaling pathway 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
408	T cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
409	T cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
410	T cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
411	T cell receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
412	TGF-beta signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
413	TGF-beta signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
414	Th1 and Th2 cell differentiation 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
415	Th1 and Th2 cell differentiation 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
416	Th1 and Th2 cell differentiation 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
417	Th1 and Th2 cell differentiation 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
418	Th1 and Th2 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
419	Th1 and Th2 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
420	Th1 and Th2 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
421	Th17 cell differentiation 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
422	Th17 cell differentiation 💬	2件: IL1B, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
423	Th17 cell differentiation 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
424	Th17 cell differentiation 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
425	Th17 cell differentiation 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
426	Th17 cell differentiation 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
427	Th17 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
428	Th17 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
429	Th17 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
430	Thermogenesis 💬	1件: FGFR1 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
431	Thermogenesis 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
432	Thyroid hormone signaling pathway 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
433	TNF signaling pathway 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
434	TNF signaling pathway 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
435	Toll-like receptor signaling pathway 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
436	Toll-like receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
437	Toxoplasmosis 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
438	Toxoplasmosis 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
439	Toxoplasmosis 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
440	Toxoplasmosis 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
441	Toxoplasmosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
442	Transcriptional misregulation in cancer 💬	1件: FLT1 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
443	Transcriptional misregulation in cancer 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
444	Tuberculosis 💬	2件: IFNGR1, IFNGR2 💬	D00747 💬	Interferon gamma-1b	7件: 18, 65, 85, 228, 299, 301, 326 💬
445	Tuberculosis 💬	5件: IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
446	Tuberculosis 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
447	Tuberculosis 💬	2件: JAK1, JAK2 💬	D09959 💬	Ruxolitinib	1件: 228 💬
448	Tuberculosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
449	Tuberculosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
450	Tuberculosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
451	Tuberculosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
452	Tuberculosis 💬	1件: VDR 💬	D00188 💬	Cholecalciferol	23件: 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
453	Type I diabetes mellitus 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
454	Type I diabetes mellitus 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
455	Type II diabetes mellitus 💬	1件: MTOR 💬	D02714 💬	Everolimus	9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
456	Type II diabetes mellitus 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
457	Type II diabetes mellitus 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
458	VEGF signaling pathway 💬	1件: KDR 💬	D10481 💬	Nintedanib	5件: 51, 85, 89, 227, 228 💬
459	VEGF signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
460	VEGF signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
461	VEGF signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
462	Viral carcinogenesis 💬	1件: JAK1 💬	D10944 💬	Itacitinib	5件: 46, 51, 60, 97, 228 💬
463	Viral carcinogenesis 💬	1件: JAK1 💬	D09959 💬	Ruxolitinib	1件: 228 💬
464	Viral protein interaction with cytokine and cytokine receptor 💬	4件: CCL2, IL10, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
465	Viral protein interaction with cytokine and cytokine receptor 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
466	Viral protein interaction with cytokine and cytokine receptor 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
467	Wnt signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
468	Wnt signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
469	Wnt signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
470	Yersinia infection 💬	5件: CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
471	Yersinia infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬

先頭へ